Atlas Trials

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

Clinical trial NCT04523246 · COMPLETED

Trial details

NCT number
NCT04523246
Sponsor
University of Oklahoma
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Herpes ZosterAllergy and ImmunologyCorona Virus Infection
Start date
2020-09-01
Primary completion
2021-12-30
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.